Skip to content

Clinical trials

Expanded access Lymphoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma Phase: Expanded access Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available8
Approved for marketing2
Available2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ADC Therapeutics S.A.1
AbbVie1
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Atara Biotherapeutics1
BTG International Inc.1
Barbara Ann Karmanos Cancer Institute1
Christopher Dvorak1
Genmab1
Joanne Kurtzberg, MD1
Molecular Templates, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma12
Leukemia4
Leukemia, Myeloid, Acute3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma, Non-Hodgkin3
Myelodysplastic Syndromes3
Neoplasms3
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Recurrence3
Hematologic Diseases2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.